122 related articles for article (PubMed ID: 23738752)
1. Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.
Chen WC; Lai YH; Chen HY; Guo HR; Su IJ; Chen HH
Histopathology; 2013 Aug; 63(2):225-33. PubMed ID: 23738752
[TBL] [Abstract][Full Text] [Related]
2. Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
Ali HR; Provenzano E; Dawson SJ; Blows FM; Liu B; Shah M; Earl HM; Poole CJ; Hiller L; Dunn JA; Bowden SJ; Twelves C; Bartlett JM; Mahmoud SM; Rakha E; Ellis IO; Liu S; Gao D; Nielsen TO; Pharoah PD; Caldas C
Ann Oncol; 2014 Aug; 25(8):1536-43. PubMed ID: 24915873
[TBL] [Abstract][Full Text] [Related]
3. The Immunology of Hormone Receptor Positive Breast Cancer.
Goldberg J; Pastorello RG; Vallius T; Davis J; Cui YX; Agudo J; Waks AG; Keenan T; McAllister SS; Tolaney SM; Mittendorf EA; Guerriero JL
Front Immunol; 2021; 12():674192. PubMed ID: 34135901
[TBL] [Abstract][Full Text] [Related]
4. An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer.
Maley CC; Koelble K; Natrajan R; Aktipis A; Yuan Y
Breast Cancer Res; 2015 Sep; 17(1):131. PubMed ID: 26395345
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value and tumour microenvironment characteristics of the Glasgow Microenvironment Score in primary triple-negative breast cancer.
Lu X; Wang Y; He M; Gou Z
J Clin Pathol; 2024 Jan; 77(2):128-134. PubMed ID: 36600565
[TBL] [Abstract][Full Text] [Related]
6. The Tumor Immune Microenvironment in Breast Cancer Progression.
Otterlei Fjørtoft M; Huse K; Rye IH
Acta Oncol; 2024 May; 63():359-367. PubMed ID: 38779867
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Interleukin-17 A Levels in Patients with Breast Carcinoma.
El-Batal HM; Kamel MM; Moaz I; Gohar NM
Egypt J Immunol; 2024 Jan; 31(1):174-183. PubMed ID: 38225776
[TBL] [Abstract][Full Text] [Related]
8. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.
Cochaud S; Giustiniani J; Thomas C; Laprevotte E; Garbar C; Savoye AM; Curé H; Mascaux C; Alberici G; Bonnefoy N; Eliaou JF; Bensussan A; Bastid J
Sci Rep; 2013 Dec; 3():3456. PubMed ID: 24316750
[TBL] [Abstract][Full Text] [Related]
9. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.
Coffelt SB; Kersten K; Doornebal CW; Weiden J; Vrijland K; Hau CS; Verstegen NJM; Ciampricotti M; Hawinkels LJAC; Jonkers J; de Visser KE
Nature; 2015 Jun; 522(7556):345-348. PubMed ID: 25822788
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study.
Dieci MV; Criscitiello C; Goubar A; Viale G; Conte P; Guarneri V; Ficarra G; Mathieu MC; Delaloge S; Curigliano G; Andre F
Ann Oncol; 2014 Mar; 25(3):611-618. PubMed ID: 24401929
[TBL] [Abstract][Full Text] [Related]
11. Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.
Seo AN; Lee HJ; Kim EJ; Kim HJ; Jang MH; Lee HE; Kim YJ; Kim JH; Park SY
Br J Cancer; 2013 Nov; 109(10):2705-13. PubMed ID: 24129232
[TBL] [Abstract][Full Text] [Related]
12. Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target.
Varisli L; Dancik GM; Tolan V; Vlahopoulos S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958417
[TBL] [Abstract][Full Text] [Related]
13. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis.
Zareinejad M; Mehdipour F; Roshan-Zamir M; Faghih Z; Ghaderi A
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835465
[TBL] [Abstract][Full Text] [Related]
14. Innate Immunity in Cancer Biology and Therapy.
Zhang Y; Xue W; Xu C; Nan Y; Mei S; Ju D; Wang S; Zhang X
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37510993
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 17 in early invasive breast cancer.
Popović M; Dedić Plavetić N; Vrbanec D; Marušić Z; Mijatović D; Kulić A
Front Oncol; 2023; 13():1171254. PubMed ID: 37427128
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration.
Khalid F; Takagi K; Sato A; Yamaguchi M; Guestini F; Miki Y; Miyashita M; Hirakawa H; Ohi Y; Rai Y; Sagara Y; Sasano H; Suzuki T
Breast Cancer; 2023 Sep; 30(5):748-757. PubMed ID: 37178415
[TBL] [Abstract][Full Text] [Related]
17. Development of a nomogram based on serum cytokine-related riskscore in breast cancer.
Zhu Y; He Y; Chen C; Zhang J; Yang X; Lu Y; Chen YZ; Zhao W
Front Oncol; 2023; 13():1146463. PubMed ID: 37007080
[TBL] [Abstract][Full Text] [Related]
18. The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target.
Shibabaw T; Teferi B; Ayelign B
Front Immunol; 2023; 14():1094823. PubMed ID: 36993955
[TBL] [Abstract][Full Text] [Related]
19. Protective Role of
Aleksandrova E; Vlaykova T; Ananiev J; Gulubova M
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422171
[No Abstract] [Full Text] [Related]
20. Oral Microbiota from Periodontitis Promote Oral Squamous Cell Carcinoma Development via γδ T Cell Activation.
Wei W; Li J; Shen X; Lyu J; Yan C; Tang B; Ma W; Xie H; Zhao L; Cheng L; Deng Y; Li Y
mSystems; 2022 Oct; 7(5):e0046922. PubMed ID: 36000726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
